These projections place Visteon’s (VC) projected enterprise value at $1.61 billion, or suggestive of about a 22% overvaluation. After debt- and excess cash-related adjustments, this comes to an estimated intrinsic value price of about $60 per share, or about a 20% overvaluation on the company’s equity. These figures place VC’s estimated EBITDA multiple between 5.2x-5.5x through 2017 and 4.5x long-term. In general, we have a fair price confidence range between $56-$65 per share based on WACC and perpetual growth rate sensitivity parameters of +/- 50 bps.